Trials / Completed
CompletedNCT01006993
Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator
Feasibility and Safety of NeuroFlo in Stroke Patients Receiving tPA
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- CoAxia · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To assess the safety and feasibility of using the NeuroFlo catheter to treat acute ischemic stroke patients following administration of intravenous tPA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NeuroFlo catheter | NeuroFlo™ catheter 45 minute treatment |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2009-07-01
- Completion
- 2010-01-01
- First posted
- 2009-11-03
- Last updated
- 2010-03-11
Locations
4 sites across 2 countries: Canada, Germany
Source: ClinicalTrials.gov record NCT01006993. Inclusion in this directory is not an endorsement.